JPMorgan U.S. Research Enhanced Large Cap ETF (JUSA) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
JPMorgan U.S. Research Enhanced Large Cap ETF (JUSA) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $36.1M, listed on AMEX, carrying a beta of 1.00 to the broader market. Under normal circumstances, at least 80% of the fund’s assets will be invested in the equity securities of large, well-established companies located in the United States. public since 2025-03-14.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for JUSA as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.